Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec 26;29(1):1-8.
doi: 10.3390/pathophysiology29010001.

Corneal Confocal Microscopy in the Diagnosis of Small Fiber Neuropathy: Faster, Easier, and More Efficient Than Skin Biopsy?

Affiliations
Review

Corneal Confocal Microscopy in the Diagnosis of Small Fiber Neuropathy: Faster, Easier, and More Efficient Than Skin Biopsy?

Mariia V Lukashenko et al. Pathophysiology. .

Abstract

Chronic pain may affect 30-50% of the world's population and an important cause is small fiber neuropathy (SFN). Recent research suggests that autoimmune diseases may be one of the most common causes of small nerve fiber damage. There is low awareness of SFN among patients and clinicians and it is difficult to diagnose as routine electrophysiological methods only detect large fiber abnormalities, and specialized small fiber tests, like skin biopsy and quantitative sensory testing, are not routinely available. Corneal confocal microscopy (CCM) is a rapid, non-invasive, reproducible method for quantifying small nerve fiber degeneration and regeneration, and could be an important tool for diagnosing SFN. This review considers the advantages and disadvantages of CCM and highlights the evolution of this technique from a research tool to a diagnostic test for small fiber damage, which can be a valuable contribution to the study and management of autoimmune disease.

Keywords: Sjogren’s syndrome; autoimmune neuropathies; autoimmunity; confocal microscopy (CM); cornea; sarcoidosis; skin biopsy; small fiber neuropathy (SFN).

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Layer-by-layer image of the healthy cornea. (a)—superficial epithelial cells, (b,c)—sub-basal nerve plexuses, (d,e)—stroma, and (f)—endothelium.
Figure 2
Figure 2
The sub-basal nerve plexus in (a)—healthy volunteer with normal nerve fibers, (b)—patient with diabetic neuropathy with reduced nerve fibers, and (c)—patient with diabetes and Charcot neuro-osteoarthropathy with a severe loss of nerve fibers.

Similar articles

Cited by

References

    1. Brouwer B.A., Bakkers M., Hoeijmakers J.G., Faber C.G., Merkies I.S. Improving assessment in small fiber neuropathy. J. Peripher. Nerv. Syst. 2015;20:333–340. doi: 10.1111/jns.12128. - DOI - PubMed
    1. Brines M., Culver D.A., Ferdousi M., Tannemaat M.R., Velzen van M., Dahan A., Malik A. Corneal nerve fiber size adds utility to the diagnosis and assessment of therapeutic response in patients with small fiber neuropathy. Sci. Rep. 2018;8:4734. doi: 10.1038/s41598-018-23107-w. - DOI - PMC - PubMed
    1. Hoitsma E., Reulen J.P., de Baets M., Drent M., Spaans F., Faber C.G. Small fiber neuropathy: A common and important clinical disorder. J. Neurol. Sci. 2004;227:119–130. doi: 10.1016/j.jns.2004.08.012. - DOI - PubMed
    1. Basantsova N.Y., Zinchenko Y.U.S., Starshinova A.A., Yablonsky P.K. Features of the diagnosis of small fiber neuropathies in various diseases (literature review) Pediatrician. 2018;9:101–110. doi: 10.17816/PED96101-110. - DOI
    1. Johnson S.A., Shouman K., Shelly S., Sandroni P., Berini S.E., Dyck P.J.B., Hoffman E.M., Mandrekar J., Niu Z., Lamb C.J., et al. Small Fiber Neuropathy Incidence, Prevalence, Longitudinal Impairments, and Disability. Neurology. 2021;97:e2236–e2247. doi: 10.1212/WNL.0000000000012894. - DOI - PMC - PubMed